Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO. - Ciracì, P.; Germani, M.M.; Pietrantonio, F.; Manca, P.; Lonardi, S.; Busico, A.; Bergamo, F.; Burgio, V.; Mannavola, F.; Di Donato, S.; Fenocchio, E.; Palermo, F.; et al. (Annals of Oncology, 2026)